xprioritynormal xmsmailprioritynormal xmailermicrosoft outlook build importancenormal xmimeoleproduced by microsoft mimeole v xantivirusok antivir mailgate version ave vdf untitled document investment alertemerging biotech company soon to release ground breaking medical device in vivo medical diagnostics inc stock symbol otcivvo is finalizing its first groundbreaking portable medical device the prothrombin time monitor that measures changes in the magnetic fields of blood on a molecular levele this is critical for patients undergoing anticoagulation therapy after heart attacks and strokese this measurement is now portable and is used in real time to achieve optimal medication levels which is essential for successful treatmente ivvo has recently announced their joint effort with inverness medical innovations a leading manufacturer and marketer of rapid diagnostic products in order to complete development of the prothrombin time monitor for its clinical trialse prothrombin testing is a massive market and continues to grow with projections in excess of million inand over million by e ivvo is poised to capitalize on this significant opportunitye donâ€™t miss out on the near term upside potential in ivvo investment anaysis in vivo medical diagnostics ince stock symbol otcivvo shortterm target e month target e recommendationsvery strong buy long term outlookexcellent heart disease is the most common cause of death and cardiovascular disease affects overmillion people worldwidee the largest area ofgrowth in the health care sector is in patient managemente this growth is caused by patients with chronic conditions who are forced to make frequent and costly hospital visits to monitor their conditione in vivo medical diagnostics utilizes the hall effect which is a wellknown physics phenomenon that can be used to measure changes in magnetic fields at the molecular levele ivvo has taken this proven science andhas used it for imaging purposes which is applied to many different applicationsincluding the cardiovascular and diabetes markets e ivvo is a wellestablished company that has been operating for over eight yearse ivvo currently has two additional products in their nd clinical trials a pregnancy labor monitor and a fetal heart rate monitor alongwithpatents that will allow them to extend their technology to other emerging medical solutionse ivvo is currently profitable with additional royalty income beginning in e ivvo has sufficient funds on hand to take them well into e information within this email contains forward looking statements within the meaning of section a of the securities act ofand section b of the securities exchange act of e any statements that express or involve discussions with respect to predictions goals expectations beliefs plans projections objectives assumptions or future events or performance are not statements of historical fact and may be forward looking statementseplease be advised that nothing within this email shall constitute a solicitation or an offer to buy or sell any security mentioned hereine this newsletter is neither a registered investment advisor nor affiliated with any broker or dealere this newsletter is not affiliated with in vivo medical diagnostics incin any waye this newsletter was produced and distributed by a independent third partye all statements made are our express opinion only and should be treated as suche we may own buy and sell any securities mentioned at any timee this report includes forwardlooking statements within the meaning of the private securitieslitigation reform act of e these statements may include terms as expect believe may will move undervalued and intend or similar termse please do your own due diligence before investing in any profiled companye you may lose money from investing in penny stockse 